CLASS ACTION UPDATE for BSX, TCDA and BTBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / January 22, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
BSX Shareholders Click Here: https://www.zlk.com/pslra-1/boston-scientific-corporation-loss-submission-form?prid=12365&wire=1
TCDA Shareholders Click Here: https://www.zlk.com/pslra-1/tricida-inc-loss-submission-form?prid=12365&wire=1
BTBT Shareholders Click Here: https://www.zlk.com/pslra-1/bit-digital-inc-loss-submission-form?prid=12365&wire=1
* ADDITIONAL INFORMATION BELOW *
Boston Scientific Corporation (NYSE:BSX)
BSX Lawsuit on behalf of: investors who purchased April 24, 2019 - November 16, 2020
Lead Plaintiff Deadline : February 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/boston-scientific-corporation-loss-submission-form?prid=12365&wire=1
According to the filed complaint, during the class period, Boston Scientific Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) the LOTUS Edge Aortic Valve System's product delivery system was dysfunctional and threatened the continued viability of the entire product line; (ii) as a result, the Company had materially overstated the continued commercial viability and profitability of the LOTUS Edge Aortic Valve System; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Tricida, Inc. (NASDAQ:TCDA)
TCDA Lawsuit on behalf of: investors who purchased September 4, 2019 - October 28, 2020
Lead Plaintiff Deadline : March 8, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tricida-inc-loss-submission-form?prid=12365&wire=1
According to the filed complaint, during the class period, Tricida, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Bit Digital, Inc. (NASDAQ:BTBT)
BTBT Lawsuit on behalf of: investors who purchased December 21, 2020 - January 8, 2021
Lead Plaintiff Deadline : March 22, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/bit-digital-inc-loss-submission-form?prid=12365&wire=1
According to the filed complaint, during the class period, Bit Digital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that Bit Digital overstated the extent of its a bitcoin mining operation; and (2) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
https://www.accesswire.com/625467/CLASS-ACTION-UPDATE-for-BSX-TCDA-and-BTBT-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders
